SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 515 filers reported holding SEAGEN INC in Q4 2021. The put-call ratio across all filers is 0.83 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,063,409 | +13.1% | 278,404 | -6.0% | 0.12% | +15.2% |
| Q2 2023 | $52,239,218 | -17.9% | 296,129 | -13.3% | 0.10% | -22.2% |
| Q1 2023 | $63,627,332 | +138175.2% | 341,423 | -4.6% | 0.14% | +55.2% |
| Q4 2022 | $46,015 | -99.9% | 358,069 | +39.0% | 0.09% | -6.5% |
| Q3 2022 | $35,975,000 | -48.9% | 257,569 | -38.1% | 0.09% | -43.6% |
| Q2 2022 | $70,462,000 | -0.4% | 416,323 | -23.8% | 0.16% | +23.1% |
| Q1 2022 | $70,726,000 | -5.5% | 546,291 | -0.8% | 0.13% | +5.5% |
| Q4 2021 | $74,838,000 | +514.7% | 550,491 | +562.5% | 0.13% | +477.3% |
| Q3 2021 | $12,174,000 | -4.8% | 83,091 | -13.5% | 0.02% | 0.0% |
| Q2 2021 | $12,793,000 | +41.2% | 96,091 | +25.3% | 0.02% | +46.7% |
| Q1 2021 | $9,061,000 | -48.5% | 76,691 | -37.6% | 0.02% | -48.3% |
| Q4 2020 | $17,590,000 | – | 122,885 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |